REGIONAL DISTRIBUTION AND KINETICS OF 3 SITES ON THE GABA-A RECEPTOR - LACK OF EFFECT OF PORTACAVAL SHUNTING

被引:21
作者
MANS, AM
KUKULKA, KM
MCAVOY, KJ
ROKOSZ, NC
机构
[1] Department of Physiology, Chicago Medical School, University of Health Sciences, North Chicago, IL
[2] Department of Physiology, Chicago Medical School, University of Health Sciences, North Chicago, IL 60064
关键词
GABA NEUROTRANSMISSION; BENZODIAZEPINE; MUSCIMOL; TBPS; HEPATIC ENCEPHALOPATHY;
D O I
10.1038/jcbfm.1992.46
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The regional distribution of binding sites on the GABA(A) receptor and their kinetic parameters were measured by quantitative autoradiography in brains from normal rats and rats with a portacaval shunt, a model of portal systemic encephalopathy in which GABA neurotransmission may be altered. The ligands used were [H-3]flunitrazepam (a benzodiazepine-site agonist), [H-3]Ro15-1788 (a benzodiazepine-site antagonist), [H-3]muscimol (a GABA-site agonist), and [S-35]t-butylbicyclo-phosphorothionate (S-35-TBPS, a convulsant that binds to a site near the chloride channel). Some brains were analyzed by computerized image analysis and three-dimensional reconstruction. The regional distribution of binding of the benzodiazepines was very similar, but the patterns obtained with [H-3]muscimol and [S-35]TBPS were different in many areas, suggesting a heterogeneous distribution of several subtypes of the GABA(A) receptor. The kinetic parameters were determined in brain regions for [H-3]flunitrazepam, [H-3]Ro15-1788, and [H-3]muscimol. For each ligand, the K(d) showed a significant heterogeneity among brain regions (at least threefold), contrary to conclusions drawn from earlier studies. In portacaval shunted rats, binding of all four ligands was essentially unchanged from that in control rats, indicating that, if there was an abnormality in GABA neurotransmission during portal systemic shunting, it was not reflected by altered binding to the main sites on the GABA(A) receptor.
引用
收藏
页码:334 / 346
页数:13
相关论文
共 68 条
[1]   DIFFERENTIAL-EFFECTS OF IODIDE AND CHLORIDE ON ALLOSTERIC INTERACTIONS OF THE GABA-A RECEPTOR [J].
ABEL, MS ;
BLUME, AJ ;
GARRETT, KM .
JOURNAL OF NEUROCHEMISTRY, 1989, 53 (03) :940-945
[2]  
BAKTI G, 1987, HEPATOLOGY, V4, P629
[3]   EXPERIMENTAL HEPATIC-ENCEPHALOPATHY - CHANGES IN THE BINDING OF GAMMA-AMINOBUTYRIC ACID [J].
BARALDI, M ;
ZENEROLI, ML .
SCIENCE, 1982, 216 (4544) :427-429
[4]  
BASILE AS, 1990, NEUROPSYCHOPHARMACOL, V3, P61
[5]   AMELIORATION OF HEPATIC-ENCEPHALOPATHY BY PHARMACOLOGICAL ANTAGONISM OF THE GABA-A-BENZODIAZEPINE RECEPTOR COMPLEX IN A RABBIT MODEL OF FULMINANT HEPATIC-FAILURE [J].
BASSETT, ML ;
MULLEN, KD ;
SKOLNICK, P ;
JONES, EA .
GASTROENTEROLOGY, 1987, 93 (05) :1069-1077
[6]   GABA-A AND GABA-B RECEPTOR-SITE DISTRIBUTION IN THE RAT CENTRAL-NERVOUS-SYSTEM [J].
BOWERY, NG ;
HUDSON, AL ;
PRICE, GW .
NEUROSCIENCE, 1987, 20 (02) :365-383
[7]   GABA RECEPTOR MULTIPLICITY - VISUALIZATION OF DIFFERENT RECEPTOR TYPES IN THE MAMMALIAN CNS [J].
BOWERY, NG ;
PRICE, GW ;
HUDSON, AL ;
HILL, DR ;
WILKIN, GP ;
TURNBULL, MJ .
NEUROPHARMACOLOGY, 1984, 23 (2B) :219-231
[8]   BENZODIAZEPINE RECEPTOR LIGANDS WITH POSITIVE AND NEGATIVE EFFICACY [J].
BRAESTRUP, C ;
NIELSEN, M ;
HONORE, T ;
JENSEN, LH ;
PETERSEN, EN .
NEUROPHARMACOLOGY, 1983, 22 (12B) :1451-1457
[9]   INTRAVENOUS ADMINISTRATION OF DIAZEPAM IN PATIENTS WITH CHRONIC LIVER-DISEASE [J].
BRANCH, RA ;
MORGAN, MH ;
JAMES, J ;
READ, AE .
GUT, 1976, 17 (12) :975-983
[10]  
BROWNER M, 1981, J NEUROSCI, V1, P514